ReviewRenal failure2025
Optimizing hemodialysis management using bioelectrical impedance analysis: emphasizing the significance of the phase angle.
Review in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Screening effect of phase angle and calf circumference in different stages of sarcopenia in patients with maintenance hemodialysis.BMC musculoskeletal disorders · 2026Article
- Integrated Ultrasound Approach to Fluid Assessment and Nutritional Status in Hemodialysis.Cardiorenal medicine · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients undergoing hemodialysis (HD) often experience complications, such as severe malnutrition, muscle wasting, and fluid overload, which significantly affect survival rates and quality of life. Accurate assessment and management of nutritional status and fluid retention are essential for improving patient outcomes. Bioelectrical impedance analysis (BIA), a noninvasive and practical tool, is increasingly used to assess body composition and fluid distribution in patients undergoing HD. The phase angle (PhA), a BIA parameter, reflects cellular integrity and serves as a reliable indicator of nutritional status and clinical prognosis. This review discusses the clinical utility of BIA in assessing nutritional status, fluid retention, and body composition in patients undergoing maintenance HD, with a particular focus on the PhA. The role of the PhA in predicting survival, frailty, sarcopenia, and erythropoiesis-stimulating agent resistance was explored. The application of personalized dry weight management guided by BIA has been proposed to optimize the care of patients undergoing HD. Despite limitations, including inter-device variability, lack of standardized cutoff values, and limited evidence, BIA represents a promising tool that may enhance clinical outcomes if integrated into routine clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.